Baysient Unveils Enhanced iDose® GEN7.0 for Precision Dosing in 16 Inflammatory Conditions Baysient has launched iDose® GEN7.0, a precision dosing platform now supporting 17 inflammatory diseases, improving treatment outcomes in various specialties.

Baysient Unveils Enhanced iDose® GEN7.0 for Precision Dosing in 16 Inflammatory Conditions #USA #Fort_Myers #precision_dosing #Baysient #iDose

InsightRX Recognized as Leader in Precision Dosing with Outstanding KLAS Performance Score InsightRX has made a significant mark in the KLAS Spotlight 2025, achieving a 96.1 performance score. This marks its leadership as a precision dosing solution.

InsightRX Recognized as Leader in Precision Dosing with Outstanding KLAS Performance Score #USA #San_Francisco #InsightRX #KLAS #precision_dosing